WORLD’S-FIRST HUMAN PANCREATIC CANCER MODEL CREATED

“With our model, we’ve confidently shown now that we can go up to 12 days and maintain the whole tumour architecture. That architecture is what’s really the game-changer in pancreatic cancer… as we can very closely study the biology of these cells and hopefully, this will lead us to new insights into how pancreatic tumours grow and spread around the body.”

Kokkinos adds that the benefit of this longevity is there is a greater potential for testing the effect of different chemotherapy drugs on the cancer, and offering personalised treatments to patients in the future.

The benefit of this longevity is there is a greater potential for testing the effect of different chemotherapy drugs on the cancer, and offering personalised treatments to patients in the future.

Read The Entire Article: https://tinyurl.com/y62zrpe8